Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Arbutus Biopharma Corporation (ABUS) had Non-Operating Income/Expense of $69.61M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$0.30M |
|
$59.12M |
|
-- |
|
$0.30M |
|
$10.79M |
|
$-10.49M |
|
|
Non-Operating Income/Expense |
$69.61M |
$59.12M |
|
$59.12M |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.49M |
|
$-10.48M |
|
198.68M |
|
199.63M |
|
$0.30 |
|
$0.30 |
|
| Balance Sheet Financials | |
$339.57M |
|
-- |
|
$0.13M |
|
$339.70M |
|
$241.93M |
|
-- |
|
$12.02M |
|
$253.95M |
|
$85.75M |
|
$85.75M |
|
$85.75M |
|
199.28M |
|
| Cash Flow Statement Financials | |
$225.68M |
|
$1.04M |
|
$19.47M |
|
$18.01M |
|
$264.19M |
|
$246.18M |
|
$4.17M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.40 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-3509.70% |
|
-3509.70% |
|
-- |
|
19770.90% |
|
19770.90% |
|
$225.68M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.38 |
|
238.39 |
|
-- |
|
-- |
|
-- |
|
-- |
|
$0.43 |
|
$1.13 |
|
$1.13 |
|